NFKB1 and neoplasm: Previous studies indicated that NF-κB can induce EMT via various molecular pathways, which differ according to cell type, but resulting in tumor progression and metastasis17, 18 and thus, the NF-κB signal is a potential target for anti-metastatic therapy17, 19.